Latest Article 4 Nov 2022
The Medicines Control Authority of Zimbabwe (MCAZ) announced that it has approved the use of long-acting injectable cabotegravir (CAB-LA) as pre-exposure prophylaxis (PrEP) for HIV prevention. “The information submitted to support the approval of the product indicated that the product is safe, effective and of good quality. MCAZ is confident that the product will benefit […]...
Read More